Q&A: Pollution Linked to 15 Percent Increase in COVID-19 Deaths

Jos Lelieveld of the Max Planck Institute for Chemistry explains how fine particulate might contribute to deaths from COVID-19.

Written byLisa Winter
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

ABOVE: © ISTOCK.COM, FATIDO

As the COVID-19 pandemic spread around the globe early in the spring of 2020, researchers began investigating how air pollution, which has been known for decades to have deleterious effects on human health, could be affecting this respiratory disease. Inspired by the work of a group of researchers in the US who reported in April that high levels of air pollution correlated to a higher risk of dying from COVID-19, Jos Lelieveld, an atmospheric chemist at the Max Planck Institute for Chemistry, and others widened their scope, looking at more areas of the world.

The danger of pollution to respiratory health comes from tiny emissions particles that are inhaled. Fine particulate matter is defined as anything smaller than 2.5 micrometers (PM2.5). The smaller the particles, the further down the respiratory system they can get, causing big problems by way of oxidative stress and an exuberant inflammatory ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Lisa joined The Scientist in 2017. As social media editor, some of her duties include creating content, managing interactions, and developing strategies for the brand’s social media presence. She also contributes to the News & Opinion section of the website. Lisa holds a degree in Biological Sciences with a concentration in genetics, cell, and developmental biology from Arizona State University and has worked in science communication since 2012.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies